Sponsors (4)
This is not an official government website.
Copyright © 2026 PLEJ LC. All rights reserved.
Prohibits federal tax and federal health program coverage or payments for a broad set of medical treatments described as "gender transition procedures." It removes these procedures from the medical expense tax deduction and bars federal matching funds or payments under Medicaid, CHIP, Medicare, and from being required as an Essential Health Benefit under the ACA. The bill also defines "gender transition" and "sex" in biologically determinative terms and specifies lists of hormonal and surgical interventions covered by the prohibitions, while carving out certain medical exceptions.
The bill reduces federal spending and clarifies which gender‑transition procedures are excluded from tax deductions and federal coverage, but it does so by removing coverage across multiple federal programs and narrowing definitions in ways that will raise costs, reduce access—especially for low‑income people, minors, and transgender individuals—and create administrative and legal uncertainty.
Taxpayers generally: federal spending and potential outlays are reduced because the bill excludes specified gender‑transition procedures from tax‑deductible treatment and from federal payment across Medicaid, CHIP, and Medicare.
Medicaid enrollees and patients with certain medical needs: Medicaid programs explicitly retain coverage for many emergency, reconstructive, differences-of-sex-development (DSD)–related, and other specified procedures, preserving coverage in these specific medical situations.
States, insurers, and providers: the bill clarifies federal boundaries (CHIP/EHB/Medicare/IRC cross‑references), preserving state authority over benefit design while setting explicit federal exclusions.
Medicaid enrollees, Medicare beneficiaries, CHIP enrollees, and people whose plans relied on EHB coverage: lose federal coverage for a wide set of gender‑affirming hormonal and surgical procedures, substantially reducing access to those services.
Low‑income individuals and families, including many children on CHIP or Medicaid: face higher out‑of‑pocket costs or loss of coverage for transition‑related care, increasing financial barriers to medically recommended treatment.
LGBTQ+ and transgender individuals (including youth) and disabled beneficiaries: encounter heightened civil‑rights, privacy, and legal‑recognition risks because the bill’s sex definitions and explicit exclusions may restrict access and create legal uncertainty.
Introduced May 5, 2025 by Claudia Tenney · Last progress May 5, 2025